Posts by Sandra Ansanay-Alex
This Summer, Geneva Becomes the Capital of Life Sciences Data
Invisible yet omnipresent, data has become one of the driving forces behind contemporary science. This summer, Geneva is set to celebrate it with #GenevaLovesData, an initiative launched by the Swiss Institute of Bioinformatics (SIB) and organised in partnership with the University of Geneva, which will feature an exhibition, conferences and a public forum exploring the…
Read MoreSwiss Champions Fund Launches with Up to CHF 100 Million for Series A/B Rounds from Venture Leaders
The first dedicated growth fund for Venture Leaders alumni in Switzerland. First close planned for Q4 2026; first investments starting in 2027. As the leading international roadshow for Swiss startups, Venture Leaders has supported some of Switzerland’s most successful technology companies over the past 20 years. But what comes after Venture Leaders? Until now, the…
Read MoreAspivix Launches a New Crowdfunding Campaign
Following the success of its first crowdfunding campaign in 2025, which raised €1.9 million from over 300 investors, Aspivix is today launching a new campaign on the Capital Cell platform. “Following the first campaign, many people told us they regretted not being able to invest, as it closed sooner than expected. This new campaign responds…
Read MoreThe Swiss Health Valley Well Represented at BIO US in San Diego
BioAlps – Western Switzerland Life Sciences Cluster, is once again at BIO International Convention 2026. The event started on Monday 22 June, up to 25 June in San Diego, California. The Swisstech Pavilion features many Swiss Health Valley startups or projects. And many companies from our region made the trip. The BIO International Convention…
Read MoreCHD signs a CLA (Convertible Loan Agreement) with Venture Kick
CHD (Connected Health Development) sarl, based at the Biopôle in Lausanne and specialized in women’s health, is proud to announce its selection for Stage II of Venture Kick, along with the signature of a CLA and a new level of financial and operational support. This milestone reflects the continued confidence of Venture Kick in the…
Read MoreThree Swiss Health Valley Startups Selected for Venture Leader Medtech
Dexterous Endoscope, MoleSense ans Optizone are among the 10 promising startups have been named to the Swiss National Medtech Team 2026 and will travel to Boston from October 11th to October 16th to pitch to investors, expand their network, and meet industry leaders. Since 2006, Venturelab has been selecting the Swiss National Startup Team. Through…
Read MoreBioAlps Executive Committee: A Farewell and a Welcome
After more than 13 years of dedicated service on the BioAlps Executive Committee, Anne-Renée Leyvraz is stespping down from her role representing both UNIL and CHUV. Her retirement marks the end of a chapter that has left a lasting imprint on the organisation and on the broader Swiss Health Valley ecosystem. As Knowledge Transfer Manager…
Read MoreIsospec Analytics and MYSTONES Get a FIT Support
The Foundation for Innovation and Technology (FIT) is awarding a Tech Growth loan of CHF 400’000 to Isospec Analytics, an EPFL spin-off specialising in the identification of biological molecules for medical research. MYSTONES, an athlete tracking platform, gets a CHF 20’000 Digital Grant. Isospec Analytics: reading the molecules of the human body to improve treatment…
Read MoreCrìa Technologies Gets a CHF 100,000 FIF Seed Tech Support
Crìa Technologies is a Geneva-based and CSEM spin out startup addressing one of the most persistent logistical challenges in the life sciences: the safe, cost-efficient transport of fragile biological materials that require precise temperature control. The company has developed the world’s first portable device capable of operating across a temperature range from +8°C to -196°C.…
Read MoreGéraldine Blanchard-Rohner Gets a SNSF Support for Her Pertussis Vaccine Research
Géraldine Blanchard-Rohner, a privat-docent in the Department of Paediatrics, Gynaecology and Obstetrics and a member of the Centre for Inflammation Research (GCIR) at the University of Geneva Faculty of Medicine, as well as head of the Paediatric Immunology, Vaccinology and Rheumatology Unit at the HUG, will lead a major research project on new-generation pertussis vaccines.…
Read More